Since the reabsorption of 1,5-AG is competitively inhibited by glucose (18), conditions of increased glucosuria (such as uncontrolled diabetes or the use of SGLT2 inhibitors) lead to increase the urinary 1,5-AG excretion and lower its blood concentrations (6, 19–22). This evidence concerns the gene SLC5A2 and diabetes mellitus.